@article{BhaskarMaLendleinetal.2015,
  author    = {Bhaskar, Thanga Bhuvanesh Vijaya and Ma, Nan and Lendlein, Andreas and Roch, Toralf},
  title     = {The interaction of human macrophage subsets with silicone as a biomaterial},
  series = {Clinical hemorheology and microcirculation : blood flow and vessels},
  volume    = {61},
  journal   = {Clinical hemorheology and microcirculation : blood flow and vessels},
  number    = {2},
  publisher = {IOS Press},
  address   = {Amsterdam},
  issn      = {1386-0291},
  doi       = {10.3233/CH-151991},
  pages     = {119 -- 133},
  year      = {2015},
  abstract  = {Silicones are widely used as biomaterials for medical devices such as extracorporeal equipments. However, there is often conflicting evidence about their supposed cell-and histocompatibility. Macrophages could mediate silicone-induced adverse responses such as foreign body reaction and fibrous encapsulation. The polarization behaviour of macrophages could determine the clinical outcome after implantation of biomaterials. Induction of classically activated macrophages (CAM) may induce and support uncontrolled inflammatory responses and undesired material degradation. In contrast, polarization into alternatively activated macrophages (AAM) is assumed to support healing processes and implant integration. This study compared the interaction of non-polarized macrophages (M0), CAM, and AAM with commercially available tissue culture polystyrene (TCP) and a medical grade silicone-based biomaterial, regarding the secretion of inflammatory mediators such as cytokines and chemokines. Firstly, by using the Limulus amoebocyte lysate (LAL) test the silicone films were shown to be free of soluble endotoxins, which is the prerequisite to investigate their interaction with primary immune cells. Primary human monocyte-derived macrophages (M0) were polarized into CAM and AAM by addition of suitable differentiation factors. These macrophage subsets were incubated on the materials for 24 hours and their viability and cytokine secretion was assessed. In comparison to TCP, cell adhesion was lower on silicone after 24 hours for all three macrophage subsets. However, compared to TCP, silicone induced higher levels of certain inflammatory and chemotactic cytokines in M0, CAM, and AAM macrophage subsets. Conclusively, it was shown that silicone has the ability to induce a pro-inflammatory state to different magnitudes dependent on the macrophage subsets. This priming of the macrophage phenotype by silicone could explain the incidence of severe foreign body complications observed in vivo.},
  language  = {en}
}
@phdthesis{Bhaskar2020,
  author    = {Bhaskar, Thanga Bhuvanesh Vijaya},
  title     = {Biomimetic layers of extracellular matrix glycoproteins as designed biointerfaces},
  school      = {Universit{\"a}t Potsdam},
  year      = {2020},
  abstract  = {The goal of regenerative medicine is to guide biological systems towards natural healing outcomes using a combination of niche-specific cells, bioactive molecules and biomaterials. In this regard, mimicking the extracellular matrix (ECM) surrounding cells and tissues in vivo is an effective strategy to modulate cell behaviors. Cellular function and phenotype is directed by the biochemical and biophysical signals present in the complex 3D network of ECMs composed mainly of glycoproteins and hydrophilic proteoglycans. While cellular modulation in response to biophysical cues emulating ECM features has been investigated widely, the influence of biochemical display of ECM glycoproteins mimicking their presentation in vivo is not well characterized. It remains a significant challenge to build artificial biointerfaces using ECM glycoproteins that precisely match their presentation in nature in terms of morphology, orientation and conformation. This challenge becomes clear, when one understands how ECM glycoproteins self-assemble in the body. Glycoproteins produced inside the cell are secreted in the extra-cellular space, where they are bound to the cell membrane or other glycoproteins by specific interactions. This leads to elevated local concentration and 2Dspatial confinement, resulting in self-assembly by the reciprocal interactions arising from the molecular complementarity encoded in the glycoprotein domains. In this thesis, air-water (A-W) interface is presented as a suitable platform, where self-assembly parameters of ECM glycoproteins such as pH, temperature and ionic strength can be controlled to simulate in vivo conditions (Langmuir technique), resulting in the formation of glycoprotein layers with defined characteristics. The layer can be further compressed with surface barriers to enhance glycoprotein-glycoprotein contacts and defined layers of glycoproteins can be immobilized on substrates by horizontal lift and touch method, called Langmuir-Sch{\"a}fer (LS) method. Here, the benefit of Langmuir and LS methods in achieving ECM glycoprotein biointerfaces with controlled network morphology and ligand density on substrates is highlighted and contrasted with the commonly used (glyco)protein solution deposition (SO) method on substrates. In general, the (glyco)protein layer formation by SO is rather uncontrolled, influenced strongly by (glyco)protein-substrate interactions and it results in multilayers and aggregations on substrates, while the LS method results in (glyco)proteins layers with a more homogenous presentation. To achieve the goal of realizing defined ECM layers on substrates, ECM glycoproteins having the ability to self-assemble were selected: Collagen-IV (Col-IV) and fibronectin (FN). Highly packed FN layer with uniform presentation of ligands was deposited on polydimethysiloxane VIII (PDMS) by LS method, while a heterogeneous layer was formed on PDMS by SO with prominent aggregations visible. Mesenchymal stem cells (MSC) on PDMS equipped with FN by LS exhibited more homogeneous and elevated vinculin expression and weaker stress fiber formation than on PDMS equipped with FN by SO and these divergent responses could be attributed to the differences in glycoprotein presentation at the interface. Col-IV are scaffolding components of specialized ECM called basement membranes (BM), and have the propensity to form 2D networks by self-polymerization associated with cells. Col- IV behaves as a thin-disordered network at the A-W interface. As the Col-IV layer was compressed at the A-W interface using trough barriers, there was negligible change in thickness (layer thickness ~ 50 nm) or orientation of molecules. The pre-formed organization of Col-IV was transferred by LS method in a controlled fashion onto substrates meeting the wettability criterion (CA ≤ 80°). MSC adhesion (24h) on PET substrates deposited with Col-IV LS films at 10, 15 and 20 mN·m-1 surface pressures was (12269.0 ± 5856.4) cells for LS10, (16744.2 ± 1280.1) cells for LS15 and (19688.3 ± 1934.0) cells for LS20 respectively. Remarkably, by selecting the surface areal density of Col-IV on the Langmuir trough on PET, there is a linear increase between the number of adherent MSCs and the Col-IV ligand density. Further, FN has the ability to self-stabilize and form 2D networks (even without compression) while preserving native β-sheet structure at the A-W interface on a defined subphase (pH = 2). This provides the possibility to form such layers on any vessel (even on standard six-well culture plates) and the cohesive FN layers can be deposited by LS transfer, without the need for expensive LB instrumentation. Multilayers of FN can be immobilized on substrates by this approach, as easily as Layer-by-Layer method, even without the need for secondary adlayer or activated bare substrate. Thus, this facile glycoprotein coating strategy approach is accessible to many researchers to realize defined FN films on substrates for cell culture. In conclusion, Langmuir and LS methods can create biomimetic glycoprotein biointerfaces on substrates controlling aspects of presentation such as network morphology and ligand density. These methods will be utilized to produce artificial BM mimics and interstitial ECM mimics composed of more than one ECM glycoprotein layer on substrates, serving as artificial niches instructing stem cells for cell-replacement therapies in the future.},
  language  = {en}
}